• Save
estrogen
Upcoming SlideShare
Loading in...5
×

Like this? Share it with your network

Share
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
No Downloads

Views

Total Views
641
On Slideshare
641
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
1

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. BYNABEEL AHAMED
  • 2. Can induce estrous cycle in spayed animals.Primary female sex hormone.Adolf Butenandt & Edward Adeltbert Doisy isolated &determined the structure of estrogen.Estrogen-mimetic compounds(flavanoids) found inmany plants including saw palmetto, soybeans, etc…
  • 3. 1.Estradiol2.Estrone3.EstratriolNaturalMESTRANOLETHINYL-ESTRADIOLTIBOLONESTILBESTROLHEXESTROLDIENESTROL
  • 4. Synthetic substances XenoestrogensPlant products PhytoestrogensFungal products Mycoestrogens
  • 5. PREPARATIONS AVERAGE REPLACEMENT DOSAGEEthinyl estradiol 0.005-0.02mg/dMicronized estradiol 1-2mg/dEstradiol cypionate 2-5mg every 3-4 weeksEstradiol valerate 2-20mg every other weekEstropipate 1.25-2.5mg/dConjugated, esterified, or mixed estrogenic substances:Oral 0.3-1.25mg/dInjectable 0.2-2mg/dTransdermal PatchChlorotrianisene 12-25mg/dMethallenestril 3-9mg/dQuinestrol 0.1-0.2mg/week
  • 6. Available in 5,10 and 20 cm sq. delivering 0.025 mg,0.05 mg and 0.1 mg respt in 24hr for 3-4 days….An oral progestin is added for the last 10-12 days…Avoids high hepatic delivery….
  • 7. I) Female maturation: For normal sexual maturation & growth of females. Stimulate development of vagina,uterus,fallopiantubes & secondary sexual characters. Stimulate stromal & ductal development in breasts. Axillary & pubic hair….& for typical female bodycontours…II) Endometrial effects: For development of endometrial lining. But continuous exposure leads to hyperplasia ofendometrium.
  • 8. III) Metabolic effects:Anabolic nature….Decreases resorption rate of bone apoptosis ofosteoclastsIncreases levels of hepatic proteins such as transcortin,TBG, SHBG, transferrin, renin substrate & fibrinogen.Increases HDL & slight decrease in LDL( plasmacholesterol).IV) Effects on blood coagulation:Enhance coagulability of blood…..
  • 9. V) Other effects:Induces synthesis of progesterone receptors.Stimulates central components of stress system &promotes a sense of well being…Also cause loss of intravascular fluid into extracellularspace, producing edema…
  • 10. I) Primary hypogonadism: In estrogen deficient patients.. Treatment usually begins at 11-13 yrs of age…. To mimic the physiology of puberty… Start with small doses of estrogen on days 1-21 eachmonth & increase to adult doses until menopause… Progestin therapy simultaneously….
  • 11. II) HORMONE REPLACEMENT THERAPYHighly efficacious in suppressing the peri -menopausal syndromes….Dose of estrogen used is less…..conjugated estrogens-0.625mg/dayProgestin should be added for 10-12 days each month.Recent findings emphasize a number of risks &limitations….USE HRTORNOT???
  • 12. Developed specifically to be used for HRT…Suppresses menopausal syndromes & lowers raisedGn levels with a dose of 2.5mg daily…Decreased breast cancer risks..Side effects: weight gain, increased facial hair…
  • 13. Senile vaginitisAcneDelayed puberty in girlsDysmenorrhoeaCarcinoma prostateDysfunctional uterine bleeding
  • 14. Compounds that act on estrogen receptor…Can be agonists as well as antagonists….Spectrum of activity:Pure agonists (eg.natural estrogen)Mixed agonists/antagonists(eg.Tamoxifen)Pure antagonists(eg.fulvestrant)
  • 15. Name Uses Effects/locationclomifene used in anovulationantagonist athypothalamusfemarellemanaging menopausesymptoms, osteoporosisagonist at brain andboneormeloxifene contraceptionagonist at bone;antagonist at breast anduterusraloxifeneosteoporosis, breastcanceragonist at bone;antagonist at breast anduterustamoxifen breast canceragonist at bone anduterus, antagonist atbreasttoremifene breast cancerlasofoxifeneosteoporosis, breastcancer, vaginal atrophyagonist at the bone,antagonist at breast anduterus
  • 16. Antagonist in breast tissue & agonist in uterus, bone,liver & pituitary….1stSERM to be introduced…Used extensively in the treatment of breast cancer inpost-menopausal women…Dose:10-20mg twice daily….Side effects: hot flushes, vomiting, dermatitis, vaginalbleeding….
  • 17. Increase production of gonadotropins by inhibitingnegative feedback on hypothalamus….Binds to both ERα & ERβ & is a pure estrogenantagonistChief use is in sterility:50mg once daily × 5 days from 5thday of cycleAdv effects: polycystic ovarieshot flushesvertigoallergic dermatitis
  • 18. RALOXIFENE:Partialagonist/antagonists1stline drug forosteoporosis in post-menopausal womenSide effects: hot flushes,leg crampsORMELOXIFENE:Antagonist in breast &uterusFor dysfunctionaluterine bleedingSide effects: nausea,headache
  • 19. LETROZOLE:Inhibits aromatizationresulting in totalestrogen deprivationAdjuvant therapy aftermastectomy in earlybreast cancerANASTROZOLE:More potent thanletrozoleAdjuvant therapy forearly ER+ve breastcancer
  • 20. LIFE IS SHORT…..SMILE ALWAYS........HELP OTHERS……….FORGET YOUR EGO’S……GAIN KNOWLEDGE……FORGIVE EVERYONE…..& REMEMBER…..YOUR HAPPINESS IS DEFINED BY NONE BUTYOU……-an anonymousphilosopher